Dihydrofolate Reductase/DHFR Antibody [Dylight 550]
Novus Biologicals, part of Bio-Techne | Catalog # AF7934L

Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunocytochemistry, Western Blot
Label
DyLight 550 (Excitation = 562 nm, Emission = 576 nm)
Antibody Source
Polyclonal Sheep IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
E. coli-derived recombinant human Dihydrofolate Reductase/DHFR
Met1-Asp187
Accession # P00374
Met1-Asp187
Accession # P00374
Specificity
Detects human Dihydrofolate Reductase/DHFR in direct ELISAs and Western blots.
Clonality
Polyclonal
Host
Sheep
Isotype
IgG
Applications for Dihydrofolate Reductase/DHFR Antibody [Dylight 550]
Application
Recommended Usage
Immunocytochemistry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Dihydrofolate Reductase/DHFR
Alternate Names
DHFR, DHFRP1, DYR
Gene Symbol
DHFR
Additional Dihydrofolate Reductase/DHFR Products
Product Documents for Dihydrofolate Reductase/DHFR Antibody [Dylight 550]
Product Specific Notices for Dihydrofolate Reductase/DHFR Antibody [Dylight 550]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...